Mandate

Vinge has advised Sveafastigheter in connection with its listing on Nasdaq First North Premier Growth Market

Vinge has advised Sveafastigheter AB (publ) (”Sveafastigheter”) in connection with its listing on Nasdaq First North Premier Growth Market. The prospectus was published on 7 October 2024 and the first day of trading is 18 October 2024.

The offering price was SEK 39.50, corresponding to a market value of Sveafastigheter of approximately SEK 7.9 billion. The offering comprises up to 88,000,000 shares, corresponding to a value of approximately SEK 3.5 billion, provided that the overallotment option is fully exercised.

Sveafastigheter is a real estate company that owns, actively manages and develops residential properties throughout Sweden with a focus on rental apartments in selected growth regions. The property portfolio consists of standing assets, ongoing construction and project development with a total property value of approximately SEK 27.5 billion.

Vinge’s team primarily consisted of Jesper Schönbeck, Rikard Lindahl, Joel Magnusson, Benjamin Vafaeian, Johannes Akyol, Louise Nässén and Filip Magnusson (Capital Markets and Public M&A), Kristoffer Larson and Agnes Pigg (Real Estate), Victor Ericsson, Emelie Svanberg, Ellenor Eckerborn and Marcus Svärd (Corporate Tax), Mikael Ståhl, Kamyar Najmi and William Carlberg Johansson (Banking and Finance).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025